GRADE: Higher Dose and Adjuvanted Influenza Vaccines for Persons Aged ≥65 Years
MMWR recomm. rep; 71 (1), 2022
Estimated rates of influenza-associated hospitalization and death are generally highest among individuals 65 years of age and older (1-4), an age group for whom influenza vaccine effectiveness is often lower relative to younger populations (5, 6). Two inactivated influenza vaccines approved in the U.S. f...